Cannabis Global, Inc. (CBGL)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Cannabis Global Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| August 31, 2019 | 0.0124M |
| August 31, 2018 | |
| August 31, 2017 | |
| August 31, 2016 | |
| August 31, 2015 | |
| August 31, 2014 | 0.00 |
| August 31, 2013 | 0.00 |
| Date | Value |
|---|---|
| August 31, 2012 | 0.00 |
| August 31, 2011 | 0.00 |
| August 31, 2010 | 0.00 |
| August 31, 2009 | 0.00 |
| August 31, 2008 | 0.03M |
| August 31, 2007 | 0.0265M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Filana Therapeutics, Inc. | 26.59M |
| CorMedix, Inc. | 19.33M |
| Eloxx Pharmaceuticals, Inc. | 3.056M |
| Breakthrough Chemistry, Inc. | 0.0042M |
| BioStem Technologies, Inc. | 7.086M |